Dion Kelly
Noninsulin medications have become an important part of the management
of diabetes in children and adolescents, particularly those with Type 2
diabetes and insulin resistance. This article reviews the use of noninsulin
medications in the hospitalized pediatric population, emphasizing their
safety, efficacy, and role in glucose control. We discuss various classes
of noninsulin diabetes medications, such as oral antihyperglycemics,
glucagon-like peptide-1 receptor agonists (GLP-1RAs), and SGLT-2
inhibitors, along with their indications, clinical benefits, and challenges
in the inpatient setting. The article also highlights considerations for
appropriate medication selection, potential side effects, and monitoring
requirements for hospitalized children and adolescents with diabetes.
